NeoGenomics, Inc. Operating Lease, Expense
NeoGenomics, Inc. (NEO) reported Operating Lease, Expense of $3.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-07-28
- NeoGenomics, Inc. operating lease, expense for the quarter ending 2026-06-30 was $1.51M, a 14.53% decline year-over-year.
- NeoGenomics, Inc. operating lease, expense for the quarter ending 2026-03-31 was $1.72M, a 8.59% increase year-over-year.
- NeoGenomics, Inc. operating lease, expense for the quarter ending 2025-12-31 was $1.71M, a 10.03% decline year-over-year.
- NeoGenomics, Inc. operating lease, expense for the quarter ending 2025-09-30 was $1.69M, a 24.05% decline year-over-year.
- NeoGenomics, Inc. operating lease, expense for fiscal 2025 was $6.75M, a 24.36% decline from fiscal 2024.
- NeoGenomics, Inc. operating lease, expense for fiscal 2024 was $8.93M, a 3.35% decline from fiscal 2023.
- NeoGenomics, Inc. operating lease, expense for fiscal 2023 was $9.23M, a 5.52% decline from fiscal 2022.
- NeoGenomics, Inc. operating lease, expense for fiscal 2022 was $9.78M, a 12.15% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $3.23M 10-Q · filed 2026-07-28 | $4.94M derived: sum of 3 quarters · filed 2026-07-28 | $6.63M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2026-03-31 | $1.72M 10-Q · filed 2026-04-28 | $3.43M derived: sum of 2 quarters · filed 2026-04-28 | $5.13M derived: sum of 3 quarters · filed 2026-04-28 | $6.89M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $3.41M derived: sum of 2 quarters · filed 2026-02-17 | $5.17M derived: sum of 3 quarters · filed 2026-07-28 | $6.75M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.46M derived: sum of 2 quarters · filed 2026-07-28 | $5.04M 10-Q · filed 2025-10-28 | $6.94M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $3.35M 10-Q · filed 2026-07-28 | $3.35M 10-Q · filed 2025-07-29 | $5.25M derived: sum of 3 quarters · filed 2026-07-28 | $7.48M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $1.58M 10-Q · filed 2026-04-28 | $3.49M derived: sum of 2 quarters · filed 2026-04-28 | $5.72M derived: sum of 3 quarters · filed 2026-04-28 | $8.11M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.13M derived: sum of 2 quarters · filed 2026-02-17 | $6.53M derived: sum of 3 quarters · filed 2026-02-17 | $8.93M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $4.62M derived: sum of 2 quarters · filed 2025-10-28 | $7.02M 10-Q · filed 2025-10-28 | $9.40M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $4.79M 10-Q · filed 2025-07-29 | $7.17M derived: sum of 3 quarters · filed 2026-02-17 | $9.38M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $2.40M 10-Q · filed 2025-04-29 | $4.78M derived: sum of 2 quarters · filed 2026-02-17 | $6.99M derived: sum of 3 quarters · filed 2026-02-17 | $9.31M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.59M derived: sum of 2 quarters · filed 2026-02-17 | $6.91M derived: sum of 3 quarters · filed 2026-02-17 | $9.23M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $4.53M derived: sum of 2 quarters · filed 2024-11-05 | $6.86M 10-Q · filed 2024-11-05 | $9.26M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $4.65M 10-Q · filed 2024-07-30 | $7.05M derived: sum of 3 quarters · filed 2025-02-18 | $9.43M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | $2.33M 10-Q · filed 2024-04-30 | $4.73M derived: sum of 2 quarters · filed 2025-02-18 | $7.12M derived: sum of 3 quarters · filed 2025-02-18 | $9.45M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $4.79M derived: sum of 2 quarters · filed 2025-02-18 | $7.12M derived: sum of 3 quarters · filed 2025-02-18 | $9.78M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $4.72M derived: sum of 2 quarters · filed 2023-11-06 | $7.38M 10-Q · filed 2023-11-06 | $9.92M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.99M 10-Q · filed 2023-08-08 | $7.54M derived: sum of 3 quarters · filed 2024-02-20 | $9.96M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | $2.65M 10-Q · filed 2023-05-09 | $5.20M derived: sum of 2 quarters · filed 2024-02-20 | $7.62M derived: sum of 3 quarters · filed 2024-02-20 | $9.51M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.97M derived: sum of 2 quarters · filed 2024-02-20 | $6.85M derived: sum of 3 quarters · filed 2024-02-20 | $8.72M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.30M derived: sum of 2 quarters · filed 2022-11-08 | $6.17M 10-Q · filed 2022-11-08 | $5.97M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.75M 10-Q · filed 2022-08-09 | $3.55M derived: sum of 3 quarters · filed 2023-02-24 | $5.80M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-03-31 | $1.86M 10-Q · filed 2022-05-09 | $1.67M derived: sum of 2 quarters · filed 2023-02-24 | $3.92M derived: sum of 3 quarters · filed 2023-02-24 | $6.01M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2020-12-31 | -$197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.06M derived: sum of 2 quarters · filed 2023-02-24 | $4.15M derived: sum of 3 quarters · filed 2023-02-24 | $6.17M 10-K · filed 2023-02-24 | |
| 2020-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.34M derived: sum of 2 quarters · filed 2021-11-04 | $6.37M 10-Q · filed 2021-11-04 | $8.78M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.11M 10-Q · filed 2021-08-09 | $6.52M derived: sum of 3 quarters · filed 2022-02-25 | $7.53M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $2.02M 10-Q · filed 2021-05-06 | $4.43M derived: sum of 2 quarters · filed 2022-02-25 | $5.44M derived: sum of 3 quarters · filed 2022-02-25 | $6.51M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $3.42M derived: sum of 2 quarters · filed 2022-02-25 | $4.49M derived: sum of 3 quarters · filed 2022-02-25 | $5.63M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $2.08M derived: sum of 2 quarters · filed 2020-10-29 | $3.22M 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $2.22M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $1.14M 10-Q · filed 2020-04-29 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |